Activated PI3K/AKT/CREB signal can promote cancer cell tumor proliferation, invasion, and cell cycle progression in pancreatic and prostate cancers (Tao et al., 2020; Meng et al., 2021). This evidence concerns the gene CREB1 and prostate carcinoma.